FDA
approval
· 2019-02-21
FDA Approved: ULORIC — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
Summary
FDA approved a supplemental application for ULORIC (febuxostat) from Takeda Pharmaceuticals America, Inc., reflecting an additional regulatory action for the pr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ULORIC (FEBUXOSTAT)